BNET Industries

Bayer AG

BAY is in the Manufacturing Industry

Last Fiscal Year Sales:$35.9B
  • Public
  • DE
Dow Jones Description

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and improved earning power. We already successfully reorganized the Bayer Group and further streamlined our portfolio to create a new Bayer that is focused on its corporate strengths, its customers and the markets of the future. To help us achieve this goal, we then carried out a strategic realignment in order to concentrate in future on three high-potential, agile subgroups with largely independent operations: HealthCare, CropScience and MaterialScience, supported by three service companies. Our operating companies give us the access we need to the growth markets of the future. As an inventor company, we plan to continue setting trends in research-intensive areas. Innovations are the foundation for our competitiveness and our corporate growth, and thus for our success in the future. We believe our technical and commercial expertise entails a duty to contribute to sustainable development ? a principle we wholeheartedly endorse, mindful of its social, ethical and environmental elements. In awareness of our responsibilities as a corporate citizen, we define economy, ecology and social commitment as objectives of equal rank. We seek to retain society?s confidence through performance, flexibility and open communication as we work in pursuit of our overriding corporate goals: to steadily create corporate value and generate high value-added for the benefit of our stockholders, our employees and the community in every country in which we operate.

Director, Finance
Klaus Kuhn
Number of Employees 122,100
Contact Information

Leverkusen 51368

www.bayer.com

49 (0)214 / 30-1

NAICS Code Plastics Material and Resin Manufacturing: 325211

Recent Events

  • Endo Pharma Gets a Setback

    12/11/09 - Licensing / Contract - View Story

  • Bayers Betaferon approved in China for Treatment of Multiple Sclerosis

    12/03/09 - Product Announcement - View Story

  • UPDATE 3-US FDA declines to approve Endo testosterone drug

    12/03/09 - Licensing / Contract - View Story

  • UPDATE 1-Futuragene signs licence deal with Bayer CropScience

    12/03/09 - Joint Venture / Alliance - View Story

  • Bayer and United Nations Environment Programme Launch 19th Annual International Children's...

    11/12/09 - Product Announcement - View Story

  • Bayer Consumer Care Launches CitracalR Calcium Plus Heart Health

    11/05/09 - Product Announcement - View Story

  • German drug, chemical company Bayer's Q3 net income falls 10 per cent

    10/28/09 - Financial Announcement - View Story

  • Bayer, US Onyx launch phase III trial of Nexavar in patients with non-responsive thyroid cancer

    10/24/09 - Product Announcement - View Story

  • BRIEF-Credit Suisse raises targets on European pharma cos

    10/13/09 - Bond / Stock Rating - View Story

  • Bayer accused of hiding Yaz contraceptive risk

    10/07/09 - Lawsuit Filed - View Story

  • Bayer downgraded to neutral from buy at UBS

    9/30/09 - Bond / Stock Rating - View Story

  • Abbott Laboratories to acquire Solvay Pharmaceuticals

    9/28/09 - Merger / Acquisition - View Story

  • Bayer's contested kidney cancer drug shows benefit

    9/22/09 - Lawsuit Filed - View Story

  • Bayer names new CEO

    9/22/09 - Mgmt. Change Leaving - Director - View Story

  • Bayer Introduces CONTOUR USB - The First Blood Glucose Meter With Unique Plug & Play...

    9/21/09 - Product Announcement - View Story

  • Bayer's next CEO has a year to prepare Today

    9/16/09 - Mgmt. Change Leaving - CEO - View Story

News & Analysis

bayer ag and lyondell chemical co. - All News and Analysis

Decision Makers

Name (plus bio) Position
Klaus Kuhn Director, Finance
Richard Pott Director, Strategy and Human Resources
Wolfgang Plischke Director, Innovation, Technology and Environment
Hartmut Klusik Head, Product Supply
Gary S Balkema Executive Committee Member

Board of Directors

Name (plus bio) Position
Arthur J Higgins Chairman, HealthCare
Werner Wenning Executive Chairman
Klaus Kleinfeld Board of Directors
Paul Achleitner Board of Directors

Organization Position Status
Bayer AG Director, Finance Current
University of South Carolina MBA Former

Organization Position Status
Bayer AG Director, Strategy and Human Resources Current
University of Cologne doctorate in physics Former

Organization Position Status
Bayer AG Director, Innovation, Technology and Environment Current
Bayer HealthCare AG Manager Current
Bayer HealthCare AG Board of Directors Current

Organization Position Status
Bayer AG Head, Product Supply Current

Organization Position Status
Bayer AG Chairman, HealthCare Current
Enzon Pharmaceuticals, Inc. CEO Former
Pharmaceutical Research and Manufacturers of America member Former
Bayer HealthCare, Animal Health Division Chairman Former
Enzon Pharmaceuticals, Inc. Chairman Former

Organization Position Status
Bayer AG Executive Chairman Current
Henkel AG & Co. KGaA Supervisory Board Current

Klaus Kleinfeld is president and chief executive officer of Alcoa. He joined the company in 2007 as president and chief operating officer and seven months later assumed CEO responsibilities. He has served on Alcoa's board of directors since 2003. Alcoa is a world leader in the production and management of a very sustainable product: aluminum. Nearly 75% of the aluminum ever produced since 1888 is still in use today. The company has been a technology leader since its beginning, providing more than 90% of the aluminum alloys used in aircraft and space flight; helping making automobiles lighter, without compromising safety or performance; manufacturing sheet that created the ultimate recyclable container, the aluminum beverage can; and providing building and construction industry materials that help further the green building movement. In addition, to serving customers in these markets, Alcoa also markets wheels, fastening systems, precision and investment castings, and building systems. The company has 97,000 employees in 34 countries. Before coming to Alcoa, Mr. Kleinfeld had a 20-year career with Siemens, the global electronics and industrial conglomerate, based in the U.S. and Germany, where he served as chief executive officer of Siemens AG starting in 2005. During his tenure, Mr. Kleinfeld presided over a dramatic transformation of the company, reshaping the company's portfolio around three high growth areas, resulting in increase of revenues and market capitalization nearly doubled. Prior to his service on the Managing Board of Siemens AG, Mr. Kleinfeld was President and Chief Executive Officer of Siemens Corporation, its U.S. arm and the company's largest region. In addition to serving on Alcoa's board, he is a member of the board of Bayer AG. On the personal front, Mr. Kleinfeld was born in Bremen, Germany and educated at the University of Goettingen and University of Wuerzburg, both in Germany. He holds a Ph.D in strategic management and master's degree in business administration. In his leisure time, he enjoys skiing, tennis, the arts and is a marathon runner. Mr. Kleinfeld resides in New York with his wife and children.

Organization Position Status
Alcoa, Inc. President & Chief Executive Officer Current
Bayer AG Board of Directors Current
Alcoa, Inc. Board of Directors Current
Siemens AG President & CEO Former
Siemens Corporation Chief Executive Officer Former
Alcoa, Inc. Chief Operating Officer Former
Siemens Corporation Chief Operating Officer Former
Siemens AG Chief Operations Officer, U.S. Former
Siemens AG Executive Vice President Former
Siemens AG Audit Committee Principal Former
Citigroup Inc. Board of Directors Former
Siemens AG Board of Directors Former
Siemens Corporation member Former

Organization Position Status
Allianz SE Executive Director, Finance Current
Bayer AG Board of Directors Current
Goldman, Sachs & Co. Vice President, Mergers & Acquisitions Former
Bain & Company Manager, Strategy Consulting Former

Organization Position Status
Bayer AG Executive Committee Member Current
Bayer HealthCare, Animal Health Division President, Worldwide Bayer Consumer Care Division Former
Fairleigh Dickinson University master of business administration degree Former

Executive News

  • Report from Europe: U.S. Close vs. China Rebound

    Seeking Alpha - 9/03/09 - View Story

  • Alcoa Named Component of Dow Jones Sustainability Index for Eighth Consecutive Year

    Business Wire - 9/03/09 - View Story

  • Alcoa says global aluminium demand to fall 5.5 pct -Bloomberg

    Reuters - 9/03/09 - View Story

  • Siemens To Settle Bribery Charges with Three Former Execs

    ManagingAutomation.com - 8/31/09 - View Story

  • Siemens poised to settle with ex-managers

    Forbes.com - 8/28/09 - View Story

  • UPDATE 1-Siemens poised to settle with ex-managers

    Forbes.com - 8/28/09 - View Story

  • UPDATE 1-Siemens poised to settle with ex-managers

    Reuters - 8/28/09 - View Story

  • Bayer AG (BAY.F) May Be Ready for Deals After Lost Intervet Bid

    BioSpace - 8/11/09 - View Story

  • Inventories May Temper Aluminum Rally

    The Wall Street Journal Interactive Edition - 8/11/09 - View Story

Presented by American Express